Home›Stocks›GSK

GSK — structural market context

GSK plc

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 23. Each line shows the earlier value, the later value and their dates.

Price

Close $50.75 (Oct 23) vs $51.21 (Oct 22): −0.90%.

Volume

0.55× its 20-session average (5.8M) on Oct 23.

Includes pre- and post-market trading.

Short interest

Short interest 14.8M shares (settlement Sep 30) vs 14.7M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 2 days with fails, largest 1K shares on Sep 29.

Previous file (settlements Sep 1–Sep 14, published Sep 30): 2 days with fails, largest 21K shares on Sep 3.

No new publication in this window.

Analyst rating actions

None recorded in this window.

GSK events and their magnitude

Latest SEC filing in the event study

No SEC filing for this ticker in the event study yet.

…

Open the Event Study →

GSK short interest & days to cover

SHARES SHORT
14.8M
% OF FLOAT
0.8%
DAYS TO COVER
4.1
CHANGE VS PRIOR
+1.0%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (24d ago)

GSK fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-30 · 24d297$49.35
2026-09-29 · 25d1K$49.7
2026-09-04 · 50d999$50.87

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

GSK analyst ratings

FirmActionRatingPublished
Berenberg Bankprice_target—2026-09-15
HSBCholdHold2026-09-10
RBC CapitalinitialiseSector Perform (from Outperform)2026-09-08
Morgan StanleyholdUnderweight2026-08-25

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What is GSK's short interest?
As of the FINRA settlement date 2026-09-30, GSK had 14.8M shares sold short — 0.8% of its float, with 4.1 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
What do analysts say about GSK?
The most recent action: Berenberg Bank price_target on 2026-09-15. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell GSK?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with G

GABC · German American Bancorp, Inc.GAP · The Gap, Inc.GBNXF · Gibson Energy, Inc. Common ShaGE · GE AerospaceGEF · Greif, Inc.GFS · GlobalFoundries Inc.All G →

GSK: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.